🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Earnings call: Community Healthcare Trust reports steady growth in Q3

EditorAhmed Abdulazez Abdulkadir
Published 31/10/2024, 11:42
© Reuters.
CHCT
-

On October 30, 2024, Community Healthcare (NYSE:CHCT) Trust Incorporated (CHCT) discussed its third-quarter results, revealing a slight revenue increase and a significant expansion of its credit facility. The company's revenue grew by 3.1% year-over-year to $29.6 million, and its Funds from Operations (FFO) increased to $12.8 million.

CHCT also reported the successful expansion of its revolving credit facility to $400 million, coupled with an extended maturity and reduced pricing. Despite weather-related challenges and a minor dip in occupancy rates, the company is actively managing its portfolio and tenant relationships, as well as pursuing growth through acquisitions and redevelopments.

Key Takeaways

  • CHCT's revenue rose to $29.6 million in Q3 2024, up 3.1% from the previous year.
  • FFO increased to $12.8 million, marking a growth from Q3 2023.
  • The company expanded its revolving credit facility from $150 million to $400 million, extended its maturity by five years, and reduced pricing.
  • Occupancy rates slightly declined from 92.6% to 91.3% due to lease terminations.
  • CHCT is redeveloping five properties, with three expected to start leasing in Q1 2025.
  • A new physician clinic was acquired for $6.2 million, and four more properties are expected to close in Q4 2024.
  • The quarterly dividend was raised to $0.465 per share, an annualized rate of $1.86.
  • The company is focusing on stabilizing a tenant in six properties and maintains a conservative leverage profile.
  • CHCT has 15 to 20 tenants on its watch list, none of which are top 10 tenants.
  • Outstanding loans total approximately $8.2 million across various operators.
  • Four redevelopment projects are underway, with three launching in Q1 2024.
  • A lease termination agreement will yield about $6 million annually over four years.
  • CHCT is exploring selective dispositions of non-core assets to fund growth.

Company Outlook

  • CHCT is actively managing its portfolio with a focus on redevelopment and acquisition.
  • The company is committed to returning value to shareholders through increased dividends.
  • Strategies include capital recycling and development opportunities to drive growth.

Bearish Highlights

  • Hurricanes Helene and Milton impacted some tenants, although CHCT's properties were undamaged.
  • A slight decrease in occupancy rates was noted due to lease terminations.

Bullish Highlights

  • The company's expansion of its credit facility and reduced pricing reflect financial strength.
  • CHCT's diversified portfolio and solid financial performance are attractive to lenders.
  • The ongoing redevelopment projects are expected to contribute to future revenue growth.

Misses

  • Despite overall positive results, the company is dealing with 15 to 20 tenants on its watch list.
  • There are concerns with stabilizing a tenant that occupies six properties.

Q&A Highlights

  • CEO Dave Dupuy discussed the strategy of selling non-core assets to invest in higher-yielding assets.
  • A spread of 200 to 250 basis points is expected between current equity cap rates and disposition cap rates.
  • Dupuy confirmed that the company's portfolio is diversified, with only a small fraction underperforming.
  • The timing of transactions is favorable due to a declining interest rate environment.
  • Tenant issues appear to be idiosyncratic rather than indicative of sector-wide problems.

CHCT's CEO concluded the call by thanking participants and expressing interest in future discussions, signaling ongoing engagement with investors and analysts. The company's strategic maneuvers to navigate market conditions and tenant challenges reflect a proactive approach to sustaining growth and shareholder value.

InvestingPro Insights

Community Healthcare Trust Incorporated (CHCT) continues to navigate a challenging market environment, as reflected in its recent financial performance and strategic decisions. According to InvestingPro data, CHCT's market capitalization stands at $504.03 million, with a revenue of $115.61 million for the last twelve months as of Q3 2024. This aligns with the company's reported revenue growth of 3.1% in the latest quarter.

One of the most notable InvestingPro Tips is that CHCT "pays a significant dividend to shareholders." This is substantiated by the impressive dividend yield of 9.82%, which is particularly attractive in the current market. The company's commitment to shareholder value is further emphasized by its 10-year streak of consecutive dividend raises, as highlighted in another InvestingPro Tip.

However, investors should be aware that CHCT's stock has faced challenges, with a significant 25.42% decline over the past six months. This downturn is reflected in the company's price-to-book ratio of 1.12, suggesting the stock might be undervalued relative to its book value.

Despite these headwinds, CHCT's financial position appears stable. An InvestingPro Tip indicates that "liquid assets exceed short-term obligations," which is crucial given the company's expansion of its credit facility and ongoing redevelopment projects.

For investors seeking a more comprehensive analysis, InvestingPro offers additional tips and metrics that could provide deeper insights into CHCT's financial health and future prospects. There are 5 more InvestingPro Tips available for CHCT, which could be valuable for making informed investment decisions in this complex healthcare REIT landscape.

Full transcript - Community Healthcare Trust Inc (CHCT) Q3 2024:

Operator: Welcome to the Community Healthcare Trust 2024 Third Quarter Earnings Release Conference Call. On the call today, the company will discuss its 2024 third quarter financial results. It will also discuss progress made in various aspects of its business. Following the remarks, the phone lines will be opened for a question-and-answer session. The company's earnings release was distributed last evening and has also been posted on its website, www.chct.reit. The company wants to emphasize that some of the information that may be discussed on this call will be based on information as of today, October 30, 2024, and may contain forward-looking statements that involve risk and uncertainty. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review the company's disclosures regarding forward-looking statements in its earnings release, as well as its risk factors and MD&A and its SEC filings. The company undertakes no obligation to update forward-looking statements, whether as the result of new information, future developments, or otherwise, except as may be required by law. During this call, the company will discuss GAAP and non-GAAP financial measures. A reconciliation between the two is available in its earnings release, which is posted on its website. Call participants are advised that this conference call is being recorded for playback purposes. An archive of the call will be made available on the company's investor relations website for approximately 30 days and is the property of the company. This call may not be recorded or otherwise reproduced or distributed without the company's prior written permission. Now, I would like to turn the call over to Dave Dupuy, CEO of Community Healthcare Trust. Please go ahead.

Dave Dupuy: Great. Thanks, M.J. And good morning. Thank you for joining us today for our 2024 Third Quarter Conference Call. On the call with me today is Bill Monroe, our Chief Financial Officer; Leigh Ann Stach, our Chief Accounting Officer; and Tim Meyer, our EVP of Asset Management. Our earnings announcement and supplemental data report were released last night and furnished on Form 8-K, along with our quarterly report on 10-Q. In addition, an updated investor presentation was posted to our website last night. Numerous people and businesses were severely impacted and even devastated by hurricanes Helene and Milton. Many in Florida, Western North Carolina, and East Tennessee have experienced unprecedented flooding and damage that will require months for full recovery. Although some of our tenants encountered power outages, downed trees, and other inconveniences, we were fortunate that our properties did not sustain damage from the storms. As was previously announced, we successfully increased our revolving credit facility from $150 million to $400 million, extended its maturity date five years, all while achieving lower pricing. Bill will go into more detail in his remarks, but we were very pleased with the support of our bank group, which gives credence to the overall strength and stability of CHCT. Also, I wanted to provide an update on the geriatric psychiatric hospital operator, who is a tenant in six of our properties, representing a total of approximately 79,000 square feet and base rent of $3.2 million. Although we are not yet receiving rent and interest from the tenant, the operator's consulting team has stabilized hospital staffing, reduced costs and improved processes and controls. As a result, we are seeing improved census in October. Although we do not yet know the timing or amounts the tenant may be able to pay, we continue to pursue multiple parallel paths to begin receiving rent and interest payments as soon as possible. We remain in active dialogue with the operator and its consultants and will continue to evaluate all options available to us under our leases and notes. As for the other components of the business, our occupancy decreased from 92.6% to 91.3% during the quarter, related to a couple of lease terminations and expirations, but we continue to see good leasing activity in the portfolio. In addition, we have five properties or significant portions of them that are undergoing redevelopment or significant renovations with long-term tenants in place when the renovations or redevelopment is completed. We expect three of these projects to commence their leases during the first quarter of 2025. Our weighted average remaining lease term decreased slightly from 7.1 years to 6.8 years. And during the quarter, we acquired one physician clinic for a purchase price of approximately $6.2 million and an expected return of approximately 9.3%. The property is 100% leased with a lease expiration in 2027. We have four properties under definitive purchase agreements for an aggregate expected purchase price of $8.8 million. The company's expected returns on these investments range from 9.29% to 9.5%. We expect to close on these properties in the fourth quarter of 2024. Also, the company has signed definitive purchase and sale agreements for seven properties to be acquired after completion and occupancy for an aggregate expected investment of $169.5 million. The expected return on these investments should range from 9.1% to 9.75%. We anticipate closing on these properties throughout 2025, 2026, and 2027. Despite having access to our ATM last quarter, we did not sell equity at our currently depressed share price. Given the low share price, we are actively evaluating capital recycling opportunities, and we would anticipate having sufficient capital from selected asset sales coupled with our increased revolver capacity to fund near-term acquisitions. Going forward, we will evaluate the best uses of our capital, including, if authorized, potential share repurchases, all while maintaining modest leverage levels. To wrap up, we declared our dividend for the third quarter and raised it to $46.5 cents per common share. This equates to an annualized dividend of $1.86 per share, and we are proud to have raised our dividend every quarter since our IPO. That takes care of the items I wanted to cover, so I will hand things off to Bill to discuss the numbers.

Bill Monroe: Thank you. Before I turn to our third quarter financials, I will expand on the successful closing of our credit facility refinancing two weeks ago that Dave highlighted during his remarks. The purpose of the transaction was a routine extension of upcoming debt maturities, but with strong support from 11 existing banks and one new bank, we were able to upsize our revolver, while also reducing its pricing. The result is a new five-year $400 million revolver with current drawn pricing set at SOFR plus 170 basis points, or approximately 6.5% today. While our new upsize revolver provides us with approximately $200 million of available borrowing capacity currently, we believe in the importance of continuing our modest leverage profile. And so we do not plan to use this borrowing capacity to sustain increased leverage, but it does give us enhanced flexibility to execute upon our capital allocation plans as it relates to the timing of closing acquisitions, completing dispositions for capital recycling purposes, and issuing equity depending on share price. I will now provide more details on our third quarter financial performance. Total revenue grew from $28.7 million in the third quarter of 2023 to $29.6 million in the third quarter of 2024, representing 3.1% annual growth over the same period last year. When compared to our $27.5 million of total revenue in the second quarter of 2024, it is important to remember that we had approximately $1.7 million of out of period adjustments in the second quarter of 2024 related to the reversal of rent and interest from the geriatric psychiatric hospital tenant. Normalizing for those out of period adjustments, total revenue growth quarter over quarter was approximately 1%. From an expense perspective, property operating expenses increased by approximately $414,000 quarter-over-quarter to $6 million, primarily as a result of seasonal increases in HVAC repairs and utilities expense caused by the hot summer months. General and administrative expenses increased slightly from $4.8 million in the second quarter of 2024 to $4.9 million in the third quarter of 2024. Interest expense increased from $6 million in the second quarter of 2024 to $6.3 million in the third quarter of 2024 due to the increase in borrowings under our revolving credit facility to fund acquisitions and CapEx. Moving to funds from operations, FFO was $12.8 million in the third quarter of 2024. On a quarter-over-quarter basis, FFO increased by $1.2 million from $11.6 million in the second quarter of 2024. And on a per-diluted common share basis over these periods, FFO increased from $0.43 to $0.48 per share. Adjusted funds from operations or AFFO, which adjusts for straight line rents and stock based compensation totaled $14.6 million in the third quarter of 2024. On a quarter-over-quarter basis, AFFO increased from $14.3 million in the second quarter of 2024, and on a per-diluted common share basis over these periods, AFFO increased from $0.53 to $0.55 per share. Finally, I'll highlight again that our dividend remains well covered with a current payout ratio of only 85%. That concludes our prepared remarks. MJ, we are now ready to begin the question-and-answer session.

Operator: Thank you. [Operator Instructions] Today's first question comes from Connor Mitchell with Piper Sandler. Please go ahead.

Connor Mitchell: Hey, good morning. Thanks for taking my question. I know you guys touched on it a bit, but just wondering if you could provide a little bit more or any more color on the geriatric tenants issue that popped up in the prior quarter. Just if you guys expect any leases to maybe open, how do you feel about backfilling them? Your confidence level in getting any returns from the loan that was outstanding? Just any additional color you might be able to provide at this time.

Dave Dupuy: Hey, Connor. Thanks for the question. It's -- as I said in my prepared remarks, we've -- the consultants have done a lot of work over the last several months. And I think one of the things we're excited about is they've been able to focus on the key resource -- referral sources to repair relationships and improve admissions and census. And as everybody knows, as we've talked about on these calls, and previously, that sustained level of census will translate into consistent rent and interest payments to CHCT. So we feel good about the trends that we're seeing in the business. As I mentioned also on the call, we're looking at multiple parallel paths. There have been a number of inbound sort of interests in these facilities from other operators. And what I can tell you is, the combination of performance of the operator coupled with inbound interest, I think we're going to have opportunities to get this resolved as we mentioned on our last call in a couple of quarters. But being able to predict the amounts of rent and interest and the timing of that rent and interest today is a little tricky because we haven't gotten rent and interest from the company yet, but we do expect, based on the census that we're seeing and continued strong occupancy that they will be in a position to do that.

Connor Mitchell: Yes, of course. And then maybe just to follow up, just if there's any other tenants that might have popped up on the watch list kind of since this issue has occurred. And then just a reminder, if you guys could give us a reminder of any other outstanding loans to tenants as well? I think I remember there were two for maybe an aggregate of $5 million or $6 million, but just a reminder on that as well, please. Thank you.

Dave Dupuy: Yes, thanks. There are no -- we have 15 to 20 watch list tenants and those change month over month depending on what's going on in the portfolio. I can tell you that there are no other of our top 10 tenants that are currently on our watch list. And as it relates to your question on the loans outstanding, the loans have been pretty consistent. We've got a $2.2 million loan outstanding to an operator of behavioral health facilities. We've got a little over $4 million outstanding to another operator, and then we've got one other small $2 million loan to an operator of inpatient rehab facilities. So very, very modest loan levels at this point.

Connor Mitchell: Okay. Appreciate the color there. And then maybe just switching gears. Kind of as you guys think about putting capital to work, and you mentioned the upsize revolver, the kind of lower stock price right now. I'm just curious, would you guys think about maybe looking at more development projects like the dialysis clinic discussed? And maybe that's just a source of, again, putting capital to work without having to really think about your leverage profile or the stock position at the moment?

Dave Dupuy: Yes. So, one of the things that I mentioned in the opening remarks was, I generally do an update on our redevelopment projects. We have four of those ongoing right now. And as you alluded to, those projects are almost like embedded acquisitions in the portfolio. Three of those projects we expect to come online during the first quarter, which we think is a good thing. And sort of -- we expect to generate similar returns on these projects as we do on our acquisitions. And so that's something we're focused on. Yes, we do have the dialysis LOI in place, and to the extent they're in the market, we continue to have dialogue with them, and we would look to do something with them from a development standpoint. I will say specifically on that operator that most of their activity has been acquisition of operating companies that hasn't had real estate associated with it. So there haven't been -- it's not that they haven't been active, but the acquisitions that they've done haven't had a real estate component. And so, we haven't been able to do anything as it relates to that term sheet. So -- but yes, we will continue to focus on the portfolio. We think investing in our real estate can provide us some good returns internally. And as I mentioned also, we're going to look at capital recycling opportunities selectively for non-core assets and use that as a way to continue to fund growth. And again, our goal is not to over lever the business, although we have plenty of capacity on our revolver to fund acquisitions as well.

Connor Mitchell: Okay. Thank you.

Dave Dupuy: Thanks, Connor.

Operator: The next question is from Rob Stevenson with Janney. Please go ahead.

Rob Stevenson: Good morning, guys. Dave, the $3.2 million on the geriatric tenant, is that just rent or is that rent and the interest on the notes?

Dave Dupuy: That's just rent.

Rob Stevenson: And how much is the interest on the notes when you add on to that? What's the sort of total that they should be paying you a year per year that you're not getting.

Dave Dupuy: On an annual basis would be about $6 million. It's kind of about $1.5 million per quarter.

Rob Stevenson: Okay. And then can you remind me when the last full month of payment was for this tenant?

Dave Dupuy: I think we got partial payments back in January and February.

Rob Stevenson: Okay. So the last full month would have been sometime in 2023.

Dave Dupuy: Yes, that's probably right.

Rob Stevenson: Okay. And then the three lease -- the three redevelopment projects that you're expected to come online in the first quarter, how material is the ABR off of that? How should we be thinking about that in terms of possible earnings impact?

Dave Dupuy: Rob, we haven't disclosed that. So, historically, that's not something we've disclosed, but it's going to be a meaningful pickup for us. I think, expect that to be kind of a tailwind into the first quarter and some of it is just the timing. We expect that those three projects will come online, but it's going to come online throughout the quarter and not all at the beginning, but it's -- you could think of it in in terms of about $750,000 plus of annual rent.

Rob Stevenson: Okay. That's very helpful. And then you'd mentioned dispositions, do you currently have anything under contract for sale or anything you anticipate closing by year end?

Dave Dupuy: We do. And we have a small facility. It's very, very small. So it's not material, but we have one facility that's under contract for about $650,000, and we would expect to close that by year end.

Rob Stevenson: Okay. And then the last one for me. I think the -- that pipeline that you guys have, the seven properties for $169.5 million, One of those was previously expected to close in the fourth quarter, now looks like it's going to be 2025. Was that a push out on your end? Was that a delay in construction and/or occupancy? What sort of pushed that out from the fourth quarter?

Bill Monroe: Hey, Rob, it's Bill. It was a pushback on their side just as they were getting approvals and Medicare accreditations and being in Florida and some of the hurricanes that have come through there, things are moving a little bit slower. So the property did well through the hurricanes, but the approval process has slowed down a little bit. So instead of being in the fourth quarter, we now estimate it kind of mid to late first quarter next year.

Rob Stevenson: Okay. And do you have any ability on your end to delay the timing of the close on that stuff?

Dave Dupuy: No, not on our end.

Rob Stevenson: Okay. All right, that's all for me. Thanks, guys. Appreciate the time this morning.

Dave Dupuy: Thanks, Rob.

Operator: Thank you. The next question comes from Michael Lewis with Truist Securities. Please go ahead.

Michael Lewis: Great. Thank you. So, you addressed the movement in the least percentage. It sounds like that should come back a bit. Did you collect material lease termination fee income in the third quarter?

Dave Dupuy: Michael, I appreciate the question. So nearly all of the reduction in occupancy quarter-over-quarter related to one property, which has been on cash basis and not paying rent for the last year. We did negotiate a lease termination with that tenant, which is going to be paid over four years. And there's some incentives for that tenant to prepay us. So they're going to be paying us monthly payments plus interest to -- and ultimately we're going to get that building released and get a new long-term tenant in there. So we think this is a good outcome for us. And so yes, to answer your question, there was some lease termination fees and there will be ongoing lease termination fees paid monthly based on this termination agreement.

Michael Lewis: And then, we noticed that [LifePoint] (ph) last quarter was listed as six properties representing 10.7% of your total rent. This quarter, it looks like five properties, only 8.7% of your total rent. Is this related to a LifePoint property what we just talked about or kind of what happened in the numbers there?

Dave Dupuy: Yeah, different properties. LifePoint on their side entered into a joint venture where they are no longer the primary tenant in that property. And so, same rent, same terms, but a change in ownership of the operations and so a reduction in our LifePoint concentration.

Michael Lewis: I see. And then just lastly from me, you talked about some dispositions. Anything you could say on what types of facilities you'll be looking to sell? What the cap rates might be? Are you selling off the bottom of the portfolio, or are you going to be selling sort of stuff that's more representative in the portfolio? Just anything you could say about that?

Dave Dupuy: Yes. So I mean, I think broadly speaking, Michael, we're looking at a couple of areas for recycling. First, as you mentioned, we do have a group of buildings, probably less than 10, that may not be a long-term fit for the portfolio, but these buildings tend to be smaller and in less attractive markets, and I think they're not going to raise significant amounts of capital. But we do have a much larger group of very strong performing properties. And we could sell those very selectively at very attractive cap rates. And we're currently exploring sales of both of those broad groups. Look, our ultimate goal is to grow AFFO per share, and so we would be very rifle shot and strategic about selling any of those facilities where we might be able to do -- get a gain from those sales and make sure that those gains are reinvested into the business based on the acquisition pipeline that we have in place. And so look, we don't want to raise ATM shares at our current share price. And so we're looking at this as an alternative until we get the share price where we want it and we can start issuing shares on a more regular way basis. Q - Michael Lewis Yes. I guess, you're a company that's never bought anything below, I think this is still true, never bought anything below a 9% cap rate. So I was just wondering the difference between the cost and equity or the cost of equity and the cost of selling properties, what that spread is. But it depends on the property, I guess.

Dave Dupuy: Yeah. No, it depends on the property engine. We believe that there's a huge disconnect in terms of the actual value of individual properties as it relates to where our stock is currently trading. But we feel very confident that we could do some very attractive strategic selective asset sales at very good cap rates and use those to invest in the higher yielding assets that we do on a regular way basis.

Michael Lewis: Great. Thank you very much.

Dave Dupuy: Thanks for the question.

Operator: Thank you. The next question is from Jim Kammert with Evercore. Please go ahead.

Jim Kammert: Good morning. Thank you. Just to finish on that last topic, Dave, if we could. I mean, can we talk about maybe 200 basis points or 250 basis point type spread between implied cap rate on the equity today, and do you think realistic disposition cap rates?

Dave Dupuy: I'd say that's a good range for sure.

Jim Kammert: Okay, that's helpful. And then more qualitatively looking at a tremendous job on expanding the line of credit, extending it, all those good attributes. Just if you reflect for us, what attracted the lenders, the lender group, what attributes do you think they were underwriting, if you will, that allowed you to pull this together? I'm just curious how they looked at CHCT. Thank you.

Dave Dupuy: Yes. I'll start and Bill jump in, but I -- Bill did a great job. And we -- I think the banks look at our diversified portfolio and the performance of the portfolio overall. They see a strong dividend coverage. They see modest leverage. They see -- overall, we've got a portfolio of almost 200 buildings, we've got maybe 10 or 11 of those buildings that aren't performing the way we want, but by and large, the portfolio is performing well. And so from a credit perspective, that modest leverage, history of performance, and frankly, our track record of being able to work through tenant issues and getting those successfully resolved, I think gave the bank group a great deal of confidence in the overall position and strength of CHCT. But Bill, jump in.

Bill Monroe: Yes, I would agree with all of those. Look, having good timing never hurts, right? We are in an interest rate environment where interest rates are starting to decline. Obviously, we will benefit from that. Banks will benefit from that. And so, as Dave talked about, I think our history of modest leverage and diversification and performance all strong, and we time the transaction well also.

Jim Kammert: Thank you for the color.

Operator: Thank you. The next question is from Barry Oxford with Colliers. Please go ahead.

Barry Oxford: Great, thanks guys. Real quick, you mentioned in your opening comments that none of your top 10 tenants were on the watch list. Of the tenants that you are kind of on the watch list or concerned about, is there a particular property type that is causing that, or is it just look, it's more one-off situations, Barry, than it is related to a particular healthcare?

Dave Dupuy: Yeah. No, Barry, thanks for the question. Appreciate that, but it is definitely the latter. It tends to be idiosyncratic situations, tenant by tenant situations that we run into, and it's nothing broadly we are seeing in any specific sector that we would call on unions' attention to.

Barry Oxford: Perfect. Thanks, guys. Appreciate it.

Dave Dupuy: Thanks, Barry.

Operator: Thank you. This concludes the question-and-answer session. I would now like to turn the call back over to management for any closing remarks.

Dave Dupuy: Well, thanks everybody for the good questions and everyone's interest in the business and we look forward to talking again very soon.

Operator: The conference has now concluded. Thank you for your participation. You may now disconnect your lines.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.